Eg. Lynn et al., Very low-density lipoprotein stimulates the expression of monocyte chemoattractant protein-1 in mesangial cells, KIDNEY INT, 57(4), 2000, pp. 1472-1483
Background Elevated plasma levels of very low-density lipoprotein (VLDL) ar
e associated with an increased risk for focal glomerulosclerosis, which is
analogous to atherosclerosis. One feature of focal glomerulosclerosis is th
e presence ol foam cells derived from the infiltration of circulating monoc
ytes. Mesangial cells are able to express monocyte chemoattractant protein-
1 (MCP-1). In this study, the ability of VLDL to stimulate MCP-1 expression
in mesangial cells and consequent monocyte adhesion was investigated.
Methods. For adhesion studies, mesangial cells isolated from Sprague-Dawley
rats were treated with VLDL for six hours. followed by a one-hour incubati
on with Tamm-Horsfall protein-1 (THP-1) cells. Mesangial MCP-1 mRNA levels
were determined by reverse transcription-polymerase chain reaction. MCP-1 p
rotein was determined by solid-phase immunoassay.
Results. VLDL (100 to 300 mu g/mL) significantly enhanced the expression an
d secretion of MCP-1 (54 to 285 ng/well) in mesangial cells. Such an effect
was accompanied by the increased adhesion of monocytes to mesangial cells
and later the formation of foam cells from monocytes after ingesting excess
ive amounts of VLDL lipids. VLDL-induced MCP-1 expression and monocyte adhe
sion were blocked by a protein kinase C inhibitor (staurosporine), as well
as a calcium channel blocker (diltiazem).
Conclusions. Our results demonstrate that elevated levels of VLDL. through
the action of MCP-1, may contribute to the infiltration of monocytes into t
he mesangium and subsequent foam cell formation. Hence. VLDLs may play a ro
le in the pathogenesis of focal glomerulosclerosis. One of the mechanisms o
f such effect may be mediated through the calcium-dependent protein kinase
C pathway.